Discovery of a new class of synthetic protein kinase inhibitors that suppress selective aspects of glial activation and protect against β-amyloid induced injury: A foundation for future medicinal chemistry efforts focused on targeting Alzheimer’s disease progression

Author: Watterson D.   Velentza Anastasia   Zasadzki Magdalena   Craft Jeffrey   Haiech Jacques   Eldik Linda  

Publisher: Humana Press, Inc

ISSN: 0895-8696

Source: Journal of Molecular Neuroscience, Vol.20, Iss.3, 2003-08, pp. : 411-423

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content